Significant Progress Across Multiple Programs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Significant Progress Across Multiple Programs with Key Upcoming Catalysts Beginning H2 2022 STARS Phase 3 Program of Apraglutide in Short Bowel.

Luca santarelliProgram of apraglutideVectivbio holding ag nasdaqSignificant progress across multiple programsShort bowel syndromeIntestinal failureTopline resultsRunway extends beyond anticipated releaseHost conference call todayChief executive officerNasdaq vectEctivbio ag